{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:22:24Z","timestamp":1792664544160,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00066-019-01474-1","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:26:13Z","timestamp":1559161573000},"page":"756-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Detectability and structural stability of a\u00a0liquid fiducial marker in fresh ex vivo pancreas tumour resection specimens on CT and 3T MRI","Detektierbarkeit und strukturelle Stabilit\u00e4t eines fl\u00fcssigen Bezugsmarkers in frisch resezierten Ex-vivo-Pankreastumorpr\u00e4paraten in CT und 3T-MRT"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5771-5213","authenticated-orcid":false,"given":"Sergej","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Br\u00fcckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Welsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Hampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G. C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin L.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"issue":"3","key":"1474_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ijrobp.2014.03.029","volume":"89","author":"A Van der Horst","year":"2014","unstructured":"Van der Horst A, Lens E, Wognum S et\u00a0al (2014) Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and Intratumoral fiducials compared. Int J Radiat Oncol Biol Phys 89(3):641\u2013648","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1474_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/1754-9485.12294","volume":"59","author":"M Packard","year":"2015","unstructured":"Packard M, Gayou O, Gurram K et al (2015) Use of implanted gold fiducial markers with MV-CBCT image-guided IMRT for pancreatic tumours. J\u00a0Med Imaging Radiat Oncol 59:499\u2013506","journal-title":"J Med Imaging Radiat Oncol"},{"key":"1474_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jmir.2017.03.002","volume":"48","author":"C Chortogiannos","year":"2017","unstructured":"Chortogiannos C, Moseley D, Chen J et\u00a0al (2017) Evaluation of bony anatomy versus endobiliary stents as surrogates for volumetric image guidance in pancreatic cancer. J\u00a0Med Imaging Radiat Sci 48:352\u2013359","journal-title":"J Med Imaging Radiat Sci"},{"key":"1474_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00066-017-1227-5","volume":"194","author":"S Dobiasch","year":"2018","unstructured":"Dobiasch S, Goerig NL, Fietkau R, Combs SE (2018) Essential role of radtiation therapy for the treatment of pancreatic cancer. Strahlenther Onkol 194:185\u2013195","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1474_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijrobp.2013.05.001","volume":"87","author":"A Van der Horst","year":"2013","unstructured":"Van der Horst A, Wognum S, Fajardo RD et\u00a0al (2013) Interfractional position variation of pancreatic tumors quantified using Intratumoral fiducial markers and daily cone beam computed tomography. Int J Radiat Oncol Biol Phys 87(1):202\u2013208","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1474_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1055\/s-0029-1243989","volume":"42","author":"S Varadarajulu","year":"2010","unstructured":"Varadarajulu S, Trevino JM, Shen S et al (2010) The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: a\u00a0case series. Endoscopy 42:423\u2013425","journal-title":"Endoscopy"},{"key":"1474_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s00066-017-1153-6","volume":"193","author":"E Versteijne","year":"2017","unstructured":"Versteijne E, Lens E, van der Horst A et al (2017) Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer. Strahlenther Onkol 193:630\u2013638","journal-title":"Strahlenther Onkol"},{"key":"1474_CR8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00066-018-1306-2","volume":"194","author":"R Mazzola","year":"2018","unstructured":"Mazzola R, Fersino S, Aiello D et al (2018) Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery. Strahlenther Onkol 194:835\u2013842","journal-title":"Strahlenther Onkol"},{"key":"1474_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00066-016-1053-1","volume":"192","author":"C Panje","year":"2016","unstructured":"Panje C, Andratschke N, Brunner TB, Niyazi M, Guckenberger M (2016) Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer. Strahlenther Onkol 192:875\u2013885","journal-title":"Strahlenther Onkol"},{"key":"1474_CR10","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1118\/1.4919616","volume":"42","author":"J Scherman Rydh\u00f6g","year":"2015","unstructured":"Scherman Rydh\u00f6g J, J\u00f8lck RI, Andresen TL et al (2015) Quantification and comparison of visibility and image artifacts of a\u00a0new liquid fiducial marker in a\u00a0lung phantom for image-guided radiation therapy. Med Phys 42:2818","journal-title":"Med Phys"},{"key":"1474_CR11","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1118\/1.4918753","volume":"42","author":"OJ Gurney-Champion","year":"2015","unstructured":"Gurney-Champion OJ, Lens E, van der Horst A et al (2015) Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. Med Phys 42:2638\u20132647","journal-title":"Med Phys"},{"issue":"1","key":"1474_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/mp.12670","volume":"45","author":"S Schneider","year":"2018","unstructured":"Schneider S, J\u00f8lck RI, Troost EGC et al (2018) Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a\u00a0pancreas tissue-mimicking phantom. Med Phys 45(1):37\u201347","journal-title":"Med Phys"},{"key":"1474_CR13","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1120\/jacmp.v10i1.2875","volume":"10","author":"A Giebeler","year":"2009","unstructured":"Giebeler A, Fontenot J, Balter P et\u00a0al (2009) Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer. J\u00a0Appl Clin Med Phys 10:2875","journal-title":"J Appl Clin Med Phys"},{"key":"1474_CR14","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1088\/0031-9155\/52\/11\/001","volume":"52","author":"W Newhauser","year":"2007","unstructured":"Newhauser W, Fontenot J, Koch N et\u00a0al (2007) Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate. Phys Med Biol 52:2937\u20132952","journal-title":"Phys Med Biol"},{"key":"1474_CR15","doi-asserted-by":"publisher","first-page":"i61","DOI":"10.1093\/jrr\/rrt071","volume":"54","author":"D Habermehl","year":"2013","unstructured":"Habermehl D, Henkner K, Ecker S et al (2013) Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy. J Radiat Res 54:i61\u2013i68","journal-title":"J. Radiat. Res."},{"key":"1474_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.radonc.2016.12.027","volume":"122","author":"J Scherman Rydh\u00f6g","year":"2017","unstructured":"Scherman Rydh\u00f6g J, Perrin R, J\u00f8lck R et\u00a0al (2017) Liquid fiducial marker applicability in proton therapy of locally advanced lung cancer. Radiother Oncol 122:393\u2013399","journal-title":"Radiother Oncol"},{"key":"1474_CR17","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/adhm.201300668","volume":"3","author":"RI J\u00f8lck","year":"2014","unstructured":"J\u00f8lck RI, Binderup T, Hansen AE et\u00a0al (2014) Injectable colloidal gold in a\u00a0sucrose acetate isobutyrate gelating matrix with potential use in radiation therapy. Adv Healthc Mater 3:1680\u20131687","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"1474_CR18","first-page":"75","volume":"4","author":"EGC Troost","year":"2017","unstructured":"Troost EGC, Menkel S, Enghardt W et al (2017) BioXmark\u00ae remains chemically stable following normofractionated and single-fraction high-dose proton beam irradiation. Proceedings to the 56 Annual Meeting of the Particle Therapy Cooperative Group (PTCOG). Int J Part Ther 4(1):75","journal-title":"Int J Part Ther"},{"key":"1474_CR19","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00066-017-1193-y","volume":"193","author":"S Dobiasch","year":"2017","unstructured":"Dobiasch S, Kampfer S, Burkhardt R et al (2017) BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model. Strahlenther Onkol 193:1039\u20131047","journal-title":"Strahlenther Onkol"},{"key":"1474_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.radonc.2016.06.012","volume":"121","author":"J Scherman Rydh\u00f6g","year":"2016","unstructured":"Scherman Rydh\u00f6g J, Mortensen S, Larsen K et al (2016) Liquid fiducial marker performance during radiotherapy of locally advanced non-small cell lung cancer. Radiother Oncol 121:64\u201369","journal-title":"Radiother Oncol"},{"key":"1474_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctro.2018.07.004","volume":"13","author":"SR De Blanck","year":"2018","unstructured":"De Blanck SR, Scherman-Rydh\u00f6g J, Larsen KL, al etl (2018) Long term safety and stability and visibility of a\u00a0novel liquid fiducial marker for use in image guided radiotherapy of non-small cell lung cancer. Clin Transl Radiat Oncol 13:24\u201328","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1092","key":"1474_CR22","doi-asserted-by":"publisher","first-page":"20180236","DOI":"10.1259\/bjr.20180236","volume":"91","author":"SR De Blanck","year":"2018","unstructured":"De Blanck SR, Scherman-Rydh\u00f6g J, Siemsen M, al etl (2018) Feasibility of a\u00a0novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer. Br J Radiol 91(1092):20180236","journal-title":"Br J Radiol"},{"key":"1474_CR23","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1002\/mp.12860","volume":"45","author":"R De Roover","year":"2018","unstructured":"De Roover R, Crijns W, Poels K et al (2018) Characterization of a\u00a0novel liquid fiducial marker for multi-modal image guidance in stereotactic body radiotherapy of prostate cancer. Med Phys 45:2205\u20132217","journal-title":"Med Phys"},{"issue":"1","key":"1474_CR24","doi-asserted-by":"publisher","first-page":"S651","DOI":"10.1016\/j.ijrobp.2014.05.1926","volume":"90","author":"SR Mortensen","year":"2014","unstructured":"Mortensen SR, Scherman JB, Larsen KR et\u00a0al (2014) Use of a\u00a0novel liquid fiducial marker injected with endoscopic ultrasound equipment for use in image guided radiation therapy of thoracic tumors (porcine model). Int J Radiat Oncol Biol Phys 90(1):S651","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1474_CR25","first-page":"632","volume-title":"3D slicer","author":"S Pieper","year":"2004","unstructured":"Pieper S, Halle M, Kikinis R (2004) 3D slicer. Proceedings of the 1st IEEE International Symposium on Biomedical Imaging: From Nano to Macro. vol 1, pp\u00a0632\u2013635"},{"issue":"2","key":"1474_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.radcr.2017.03.014","volume":"12","author":"O Tanaka","year":"2017","unstructured":"Tanaka O, Nishigaki Y, Hayashi H et al (2017) The advantage of iron-containing fiducial markers placed with a\u00a0thin needle for radiotherapy of liver cancer in therms of visualization on MRI: an initial experien of Gold Anchor. Radiol Case Rep 12(2):416\u2013421","journal-title":"Radiol Case Rep"},{"issue":"2","key":"1474_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ajg.2017.05.007","volume":"18","author":"M Marsico","year":"2017","unstructured":"Marsico M, Gabbani T, Lunardi S, Galli A, Biagini MR, Annese V (2017) Percutaneous ultrasound-guided fiducial marker placement for liver cancer robotic stereotactic radio-surgery treatment: A comparative analysis of three types of markers and needles. Arab J Gastroenterol 18(2):83\u201386","journal-title":"Arab J Gastroenterol"},{"issue":"2","key":"1474_CR28","doi-asserted-by":"publisher","first-page":"E242","DOI":"10.1055\/s-0043-124078","volume":"6","author":"MH Larsen","year":"2018","unstructured":"Larsen MH, Fristrup CW, Detlefsen S, Mortensen MB (2018) Prospective evaluation of EUS-guided fine needle biopsy in pancreatic mass lesions. Endosc Int Open 6(2):E242\u2013E248","journal-title":"Endosc Int Open"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01474-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T23:07:53Z","timestamp":1590620873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01474-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01474-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"14 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.\u00a0Schneider, D.E.\u00a0Aust, S.\u00a0Br\u00fcckner, T.\u00a0Welsch, J.\u00a0Hampe, E.G.C.\u00a0Troost and A.L.\u00a0Hoffmann declare that they have no competing interests regarding the research presented in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}